CDK9-IN-2
CAT:
804-HY-16462-03
Size:
10 mM / 1 mL
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
CDK9-IN-2
- CAS Number: 1263369-28-3
- UNSPSC Description: CDK9-IN-2 is a special cyclin-dependent kinase 9 (CDK9) inhibitor, extracted from patent WO/2012131594A1, compound CDKI(8), has an IC50 of 5 nM and 7 nM in H929 multiple myeloma(MM) cell line (72 hours) and A2058 skin cell line (72 hours), respectively.
- Target Antigen: CDK
- Type: Reference compound
- Related Pathways: Cell Cycle/DNA Damage
- Applications: COVID-19-anti-virus
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/cdk9-in-2.html
- Solubility: DMSO : 50 mg/mL (ultrasonic)
- Smiles: ClC1=CN=C(N[C@@H]2CC[C@@H](N)CC2)C=C1C3=NC(NCC4=CC(F)=CC=C4)=CC=C3
- Molecular Weight: 425.93
- References & Citations: [1]Michel Faure, et al. Pharmacodynamic markers associated with cyclin-dependent kinase inhibitors. From PCT Int. Appl. (2012), WO 2012131594A1
- Shipping Conditions: Room Temperature
- Clinical Information: No Development Reported